Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

InspireMD, Inc. Director's Dealing 2016

Mar 23, 2016

34187_dirs_2016-03-23_b9e4e3ea-20e5-4e9e-8fd9-8cdc3d2d9321.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2016-03-21

Reporting Person: Stuka Paul (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-03-21 Common Stock P 127119 $0.59 Acquired 267060 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-03-21 Warrants to Purchase Common Stock $0.59 P 63560 Acquired 2021-03-21 Common Stock (63560) Indirect

Footnotes

F1: The Common Stock and Warrants to purchase Common Stock were acquired as components of Units, each Unit consisting of one share of Common Stock and a Warrant to purchase one half of one share of Common Stock, at a purchase price per Unit of $0.59.

F2: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes.